Schuetz F - Search Results

1

Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study.

Schuetz F, Ehlert K, Ge Y, Schneeweiss A, Rom J, Inzkirweli N, Sohn C, Schirrmacher V, Beckhove P. Schuetz F, et al. Cancer Immunol Immunother. 2009 Jun;58(6):887-900. doi: 10.1007/s00262-008-0605-3. Epub 2008 Nov 8. Cancer Immunol Immunother. 2009. PMID: 18998129

2

Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors.

Beckhove P, Feuerer M, Dolenc M, Schuetz F, Choi C, Sommerfeldt N, Schwendemann J, Ehlert K, Altevogt P, Bastert G, Schirrmacher V, Umansky V. Beckhove P, et al. Among authors: schuetz f. J Clin Invest. 2004 Jul;114(1):67-76. doi: 10.1172/JCI20278. J Clin Invest. 2004. PMID: 15232613 Free PMC article.

3

Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapy.

Schneeweiss A, Diel I, Hensel M, Kaul S, Sinn HP, Unnebrink K, Rudlowski C, Lauschner I, Schuetz F, Egerer G, Haas R, Ho AD, Bastert G. Schneeweiss A, et al. Among authors: schuetz f. Ann Oncol. 2004 Nov;15(11):1627-32. doi: 10.1093/annonc/mdh433. Ann Oncol. 2004. PMID: 15520063 Free article.

4

Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially followed by docetaxel for early breast cancer: final results of a phase I/II trial.

Schneeweiss A, Schuetz F, Rudlowski C, Hahn M, Lauschner I, Sinn HP, von Fournier D, Sohn C. Schneeweiss A, et al. Among authors: schuetz f. Anticancer Drugs. 2005 Oct;16(9):1023-8. doi: 10.1097/01.cad.0000176508.73090.fb. Anticancer Drugs. 2005. PMID: 16162980 Clinical Trial.

5

Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer.

Thuerigen O, Schneeweiss A, Toedt G, Warnat P, Hahn M, Kramer H, Brors B, Rudlowski C, Benner A, Schuetz F, Tews B, Eils R, Sinn HP, Sohn C, Lichter P. Thuerigen O, et al. Among authors: schuetz f. J Clin Oncol. 2006 Apr 20;24(12):1839-45. doi: 10.1200/JCO.2005.04.7019. J Clin Oncol. 2006. PMID: 16622258

6

Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study.

Rupp U, Schoendorf-Holland E, Eichbaum M, Schuetz F, Lauschner I, Schmidt P, Staab A, Hanft G, Huober J, Sinn HP, Sohn C, Schneeweiss A. Rupp U, et al. Among authors: schuetz f. Anticancer Drugs. 2007 Apr;18(4):477-85. doi: 10.1097/CAD.0b013e32801403f4. Anticancer Drugs. 2007. PMID: 17351401 Clinical Trial.

7

Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study.

Eichbaum MH, Schuetz F, Khbeis T, Lauschner I, Foerster F, Sohn C, Schneeweiss A. Eichbaum MH, et al. Among authors: schuetz f. Anticancer Drugs. 2007 Sep;18(8):963-8. doi: 10.1097/CAD.0b013e328165d11a. Anticancer Drugs. 2007. PMID: 17667603 Clinical Trial.

8

Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I study.

Rom J, von Minckwitz G, Eiermann W, Sievert M, Schlehe B, Marmé F, Schuetz F, Scharf A, Eichbaum M, Sinn HP, Kaufmann M, Sohn C, Schneeweiss A. Rom J, et al. Among authors: schuetz f. Ann Oncol. 2008 Oct;19(10):1698-705. doi: 10.1093/annonc/mdn280. Epub 2008 May 13. Ann Oncol. 2008. PMID: 18477581 Free article. Clinical Trial.

9

Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up.

Diel IJ, Jaschke A, Solomayer EF, Gollan C, Bastert G, Sohn C, Schuetz F. Diel IJ, et al. Among authors: schuetz f. Ann Oncol. 2008 Dec;19(12):2007-11. doi: 10.1093/annonc/mdn429. Epub 2008 Jul 29. Ann Oncol. 2008. PMID: 18664560 Free PMC article. Clinical Trial.

10

Phase I study of apoptosis gene modulation with oblimersen within preoperative chemotherapy in patients with primary breast cancer.

Rom J, von Minckwitz G, Marmé F, Ataseven B, Kozian D, Sievert M, Schlehe B, Schuetz F, Scharf A, Kaufmann M, Sohn C, Schneeweiss A. Rom J, et al. Among authors: schuetz f. Ann Oncol. 2009 Nov;20(11):1829-35. doi: 10.1093/annonc/mdp208. Epub 2009 Jul 15. Ann Oncol. 2009. PMID: 19605509 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page